As the global economy mends, the 2021 growth of Graves Disease Treatment will have significant change from previous year. According to our (Publisher) latest study, the global Graves Disease Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Graves Disease Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Graves Disease Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Graves Disease Treatment market, reaching US$ million by the year 2028. As for the Europe Graves Disease Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Graves Disease Treatment players cover Abbott, GlaxoSmithKline plc, Merck & Co, and Pfizer, Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Graves Disease Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Anti-Thyroid Medication
Radioactive Iodine Therapy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals Pharmacies
Retail Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott
GlaxoSmithKline plc
Merck & Co
Pfizer, Inc
RLC LABS
AbbVie, Inc
Mylan N.V
Allergan, plc
Novartis AG
Apitope
Amgen INC.
Sun Pharmaceuticals Industries LTD
Immunovant Inc
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Graves Disease Treatment Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Graves Disease Treatment by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Graves Disease Treatment by Country/Region, 2017, 2022 & 2028
2.2 Graves Disease Treatment Segment by Type
2.2.1 Anti-Thyroid Medication
2.2.2 Radioactive Iodine Therapy
2.3 Graves Disease Treatment Sales by Type
2.3.1 Global Graves Disease Treatment Sales Market Share by Type (2017-2022)
2.3.2 Global Graves Disease Treatment Revenue and Market Share by Type (2017-2022)
2.3.3 Global Graves Disease Treatment Sale Price by Type (2017-2022)
2.4 Graves Disease Treatment Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Retail Pharmacies
2.5 Graves Disease Treatment Sales by Application
2.5.1 Global Graves Disease Treatment Sale Market Share by Application (2017-2022)
2.5.2 Global Graves Disease Treatment Revenue and Market Share by Application (2017-2022)
2.5.3 Global Graves Disease Treatment Sale Price by Application (2017-2022)
3 Global Graves Disease Treatment by Company
3.1 Global Graves Disease Treatment Breakdown Data by Company
3.1.1 Global Graves Disease Treatment Annual Sales by Company (2020-2022)
3.1.2 Global Graves Disease Treatment Sales Market Share by Company (2020-2022)
3.2 Global Graves Disease Treatment Annual Revenue by Company (2020-2022)
3.2.1 Global Graves Disease Treatment Revenue by Company (2020-2022)
3.2.2 Global Graves Disease Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Graves Disease Treatment Sale Price by Company
3.4 Key Manufacturers Graves Disease Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Graves Disease Treatment Product Location Distribution
3.4.2 Players Graves Disease Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Graves Disease Treatment by Geographic Region
4.1 World Historic Graves Disease Treatment Market Size by Geographic Region (2017-2022)
4.1.1 Global Graves Disease Treatment Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Graves Disease Treatment Annual Revenue by Geographic Region
4.2 World Historic Graves Disease Treatment Market Size by Country/Region (2017-2022)
4.2.1 Global Graves Disease Treatment Annual Sales by Country/Region (2017-2022)
4.2.2 Global Graves Disease Treatment Annual Revenue by Country/Region
4.3 Americas Graves Disease Treatment Sales Growth
4.4 APAC Graves Disease Treatment Sales Growth
4.5 Europe Graves Disease Treatment Sales Growth
4.6 Middle East & Africa Graves Disease Treatment Sales Growth
5 Americas
5.1 Americas Graves Disease Treatment Sales by Country
5.1.1 Americas Graves Disease Treatment Sales by Country (2017-2022)
5.1.2 Americas Graves Disease Treatment Revenue by Country (2017-2022)
5.2 Americas Graves Disease Treatment Sales by Type
5.3 Americas Graves Disease Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Graves Disease Treatment Sales by Region
6.1.1 APAC Graves Disease Treatment Sales by Region (2017-2022)
6.1.2 APAC Graves Disease Treatment Revenue by Region (2017-2022)
6.2 APAC Graves Disease Treatment Sales by Type
6.3 APAC Graves Disease Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Graves Disease Treatment by Country
7.1.1 Europe Graves Disease Treatment Sales by Country (2017-2022)
7.1.2 Europe Graves Disease Treatment Revenue by Country (2017-2022)
7.2 Europe Graves Disease Treatment Sales by Type
7.3 Europe Graves Disease Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Graves Disease Treatment by Country
8.1.1 Middle East & Africa Graves Disease Treatment Sales by Country (2017-2022)
8.1.2 Middle East & Africa Graves Disease Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Graves Disease Treatment Sales by Type
8.3 Middle East & Africa Graves Disease Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Graves Disease Treatment
10.3 Manufacturing Process Analysis of Graves Disease Treatment
10.4 Industry Chain Structure of Graves Disease Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Graves Disease Treatment Distributors
11.3 Graves Disease Treatment Customer
12 World Forecast Review for Graves Disease Treatment by Geographic Region
12.1 Global Graves Disease Treatment Market Size Forecast by Region
12.1.1 Global Graves Disease Treatment Forecast by Region (2023-2028)
12.1.2 Global Graves Disease Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Graves Disease Treatment Forecast by Type
12.7 Global Graves Disease Treatment Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Graves Disease Treatment Product Offered
13.1.3 Abbott Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 GlaxoSmithKline plc
13.2.1 GlaxoSmithKline plc Company Information
13.2.2 GlaxoSmithKline plc Graves Disease Treatment Product Offered
13.2.3 GlaxoSmithKline plc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GlaxoSmithKline plc Main Business Overview
13.2.5 GlaxoSmithKline plc Latest Developments
13.3 Merck & Co
13.3.1 Merck & Co Company Information
13.3.2 Merck & Co Graves Disease Treatment Product Offered
13.3.3 Merck & Co Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck & Co Main Business Overview
13.3.5 Merck & Co Latest Developments
13.4 Pfizer, Inc
13.4.1 Pfizer, Inc Company Information
13.4.2 Pfizer, Inc Graves Disease Treatment Product Offered
13.4.3 Pfizer, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer, Inc Main Business Overview
13.4.5 Pfizer, Inc Latest Developments
13.5 RLC LABS
13.5.1 RLC LABS Company Information
13.5.2 RLC LABS Graves Disease Treatment Product Offered
13.5.3 RLC LABS Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 RLC LABS Main Business Overview
13.5.5 RLC LABS Latest Developments
13.6 AbbVie, Inc
13.6.1 AbbVie, Inc Company Information
13.6.2 AbbVie, Inc Graves Disease Treatment Product Offered
13.6.3 AbbVie, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 AbbVie, Inc Main Business Overview
13.6.5 AbbVie, Inc Latest Developments
13.7 Mylan N.V
13.7.1 Mylan N.V Company Information
13.7.2 Mylan N.V Graves Disease Treatment Product Offered
13.7.3 Mylan N.V Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Mylan N.V Main Business Overview
13.7.5 Mylan N.V Latest Developments
13.8 Allergan, plc
13.8.1 Allergan, plc Company Information
13.8.2 Allergan, plc Graves Disease Treatment Product Offered
13.8.3 Allergan, plc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Allergan, plc Main Business Overview
13.8.5 Allergan, plc Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Graves Disease Treatment Product Offered
13.9.3 Novartis AG Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Apitope
13.10.1 Apitope Company Information
13.10.2 Apitope Graves Disease Treatment Product Offered
13.10.3 Apitope Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Apitope Main Business Overview
13.10.5 Apitope Latest Developments
13.11 Amgen INC.
13.11.1 Amgen INC. Company Information
13.11.2 Amgen INC. Graves Disease Treatment Product Offered
13.11.3 Amgen INC. Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Amgen INC. Main Business Overview
13.11.5 Amgen INC. Latest Developments
13.12 Sun Pharmaceuticals Industries LTD
13.12.1 Sun Pharmaceuticals Industries LTD Company Information
13.12.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Offered
13.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sun Pharmaceuticals Industries LTD Main Business Overview
13.12.5 Sun Pharmaceuticals Industries LTD Latest Developments
13.13 Immunovant Inc
13.13.1 Immunovant Inc Company Information
13.13.2 Immunovant Inc Graves Disease Treatment Product Offered
13.13.3 Immunovant Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Immunovant Inc Main Business Overview
13.13.5 Immunovant Inc Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Graves Disease Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Graves Disease Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Anti-Thyroid Medication
Table 4. Major Players of Radioactive Iodine Therapy
Table 5. Global Graves Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 6. Global Graves Disease Treatment Sales Market Share by Type (2017-2022)
Table 7. Global Graves Disease Treatment Revenue by Type (2017-2022) & ($ million)
Table 8. Global Graves Disease Treatment Revenue Market Share by Type (2017-2022)
Table 9. Global Graves Disease Treatment Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Graves Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 11. Global Graves Disease Treatment Sales Market Share by Application (2017-2022)
Table 12. Global Graves Disease Treatment Revenue by Application (2017-2022)
Table 13. Global Graves Disease Treatment Revenue Market Share by Application (2017-2022)
Table 14. Global Graves Disease Treatment Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Graves Disease Treatment Sales by Company (2020-2022) & (K Units)
Table 16. Global Graves Disease Treatment Sales Market Share by Company (2020-2022)
Table 17. Global Graves Disease Treatment Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Graves Disease Treatment Revenue Market Share by Company (2020-2022)
Table 19. Global Graves Disease Treatment Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Graves Disease Treatment Producing Area Distribution and Sales Area
Table 21. Players Graves Disease Treatment Products Offered
Table 22. Graves Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Graves Disease Treatment Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Graves Disease Treatment Sales Market Share Geographic Region (2017-2022)
Table 27. Global Graves Disease Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Graves Disease Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Graves Disease Treatment Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Graves Disease Treatment Sales Market Share by Country/Region (2017-2022)
Table 31. Global Graves Disease Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Graves Disease Treatment Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Graves Disease Treatment Sales by Country (2017-2022) & (K Units)
Table 34. Americas Graves Disease Treatment Sales Market Share by Country (2017-2022)
Table 35. Americas Graves Disease Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Graves Disease Treatment Revenue Market Share by Country (2017-2022)
Table 37. Americas Graves Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 38. Americas Graves Disease Treatment Sales Market Share by Type (2017-2022)
Table 39. Americas Graves Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 40. Americas Graves Disease Treatment Sales Market Share by Application (2017-2022)
Table 41. APAC Graves Disease Treatment Sales by Region (2017-2022) & (K Units)
Table 42. APAC Graves Disease Treatment Sales Market Share by Region (2017-2022)
Table 43. APAC Graves Disease Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Graves Disease Treatment Revenue Market Share by Region (2017-2022)
Table 45. APAC Graves Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 46. APAC Graves Disease Treatment Sales Market Share by Type (2017-2022)
Table 47. APAC Graves Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 48. APAC Graves Disease Treatment Sales Market Share by Application (2017-2022)
Table 49. Europe Graves Disease Treatment Sales by Country (2017-2022) & (K Units)
Table 50. Europe Graves Disease Treatment Sales Market Share by Country (2017-2022)
Table 51. Europe Graves Disease Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Graves Disease Treatment Revenue Market Share by Country (2017-2022)
Table 53. Europe Graves Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 54. Europe Graves Disease Treatment Sales Market Share by Type (2017-2022)
Table 55. Europe Graves Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 56. Europe Graves Disease Treatment Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Graves Disease Treatment Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Graves Disease Treatment Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Graves Disease Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Graves Disease Treatment Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Graves Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Graves Disease Treatment Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Graves Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Graves Disease Treatment Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Graves Disease Treatment
Table 66. Key Market Challenges & Risks of Graves Disease Treatment
Table 67. Key Industry Trends of Graves Disease Treatment
Table 68. Graves Disease Treatment Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Graves Disease Treatment Distributors List
Table 71. Graves Disease Treatment Customer List
Table 72. Global Graves Disease Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Graves Disease Treatment Sales Market Forecast by Region
Table 74. Global Graves Disease Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Graves Disease Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Graves Disease Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Graves Disease Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Graves Disease Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Graves Disease Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Graves Disease Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Graves Disease Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Graves Disease Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Graves Disease Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Graves Disease Treatment Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Graves Disease Treatment Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Graves Disease Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Graves Disease Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Graves Disease Treatment Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Graves Disease Treatment Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Graves Disease Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Graves Disease Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 92. Abbott Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Graves Disease Treatment Product Offered
Table 94. Abbott Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Abbott Main Business
Table 96. Abbott Latest Developments
Table 97. GlaxoSmithKline plc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 98. GlaxoSmithKline plc Graves Disease Treatment Product Offered
Table 99. GlaxoSmithKline plc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. GlaxoSmithKline plc Main Business
Table 101. GlaxoSmithKline plc Latest Developments
Table 102. Merck & Co Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck & Co Graves Disease Treatment Product Offered
Table 104. Merck & Co Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Merck & Co Main Business
Table 106. Merck & Co Latest Developments
Table 107. Pfizer, Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer, Inc Graves Disease Treatment Product Offered
Table 109. Pfizer, Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Pfizer, Inc Main Business
Table 111. Pfizer, Inc Latest Developments
Table 112. RLC LABS Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 113. RLC LABS Graves Disease Treatment Product Offered
Table 114. RLC LABS Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. RLC LABS Main Business
Table 116. RLC LABS Latest Developments
Table 117. AbbVie, Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 118. AbbVie, Inc Graves Disease Treatment Product Offered
Table 119. AbbVie, Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. AbbVie, Inc Main Business
Table 121. AbbVie, Inc Latest Developments
Table 122. Mylan N.V Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 123. Mylan N.V Graves Disease Treatment Product Offered
Table 124. Mylan N.V Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Mylan N.V Main Business
Table 126. Mylan N.V Latest Developments
Table 127. Allergan, plc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 128. Allergan, plc Graves Disease Treatment Product Offered
Table 129. Allergan, plc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Allergan, plc Main Business
Table 131. Allergan, plc Latest Developments
Table 132. Novartis AG Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 133. Novartis AG Graves Disease Treatment Product Offered
Table 134. Novartis AG Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Novartis AG Main Business
Table 136. Novartis AG Latest Developments
Table 137. Apitope Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 138. Apitope Graves Disease Treatment Product Offered
Table 139. Apitope Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Apitope Main Business
Table 141. Apitope Latest Developments
Table 142. Amgen INC. Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 143. Amgen INC. Graves Disease Treatment Product Offered
Table 144. Amgen INC. Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Amgen INC. Main Business
Table 146. Amgen INC. Latest Developments
Table 147. Sun Pharmaceuticals Industries LTD Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 148. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Offered
Table 149. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Sun Pharmaceuticals Industries LTD Main Business
Table 151. Sun Pharmaceuticals Industries LTD Latest Developments
Table 152. Immunovant Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 153. Immunovant Inc Graves Disease Treatment Product Offered
Table 154. Immunovant Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Immunovant Inc Main Business
Table 156. Immunovant Inc Latest Developments
List of Figures
Figure 1. Picture of Graves Disease Treatment
Figure 2. Graves Disease Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Graves Disease Treatment Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Graves Disease Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Graves Disease Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Anti-Thyroid Medication
Figure 10. Product Picture of Radioactive Iodine Therapy
Figure 11. Global Graves Disease Treatment Sales Market Share by Type in 2021
Figure 12. Global Graves Disease Treatment Revenue Market Share by Type (2017-2022)
Figure 13. Graves Disease Treatment Consumed in Hospitals Pharmacies
Figure 14. Global Graves Disease Treatment Market: Hospitals Pharmacies (2017-2022) & (K Units)
Figure 15. Graves Disease Treatment Consumed in Retail Pharmacies
Figure 16. Global Graves Disease Treatment Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 17. Global Graves Disease Treatment Sales Market Share by Application (2017-2022)
Figure 18. Global Graves Disease Treatment Revenue Market Share by Application in 2021
Figure 19. Graves Disease Treatment Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Graves Disease Treatment Revenue Market Share by Company in 2021
Figure 21. Global Graves Disease Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Graves Disease Treatment Revenue Market Share by Geographic Region in 2021
Figure 23. Global Graves Disease Treatment Sales Market Share by Region (2017-2022)
Figure 24. Global Graves Disease Treatment Revenue Market Share by Country/Region in 2021
Figure 25. Americas Graves Disease Treatment Sales 2017-2022 (K Units)
Figure 26. Americas Graves Disease Treatment Revenue 2017-2022 ($ Millions)
Figure 27. APAC Graves Disease Treatment Sales 2017-2022 (K Units)
Figure 28. APAC Graves Disease Treatment Revenue 2017-2022 ($ Millions)
Figure 29. Europe Graves Disease Treatment Sales 2017-2022 (K Units)
Figure 30. Europe Graves Disease Treatment Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Graves Disease Treatment Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Graves Disease Treatment Revenue 2017-2022 ($ Millions)
Figure 33. Americas Graves Disease Treatment Sales Market Share by Country in 2021
Figure 34. Americas Graves Disease Treatment Revenue Market Share by Country in 2021
Figure 35. United States Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Graves Disease Treatment Sales Market Share by Region in 2021
Figure 40. APAC Graves Disease Treatment Revenue Market Share by Regions in 2021
Figure 41. China Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Graves Disease Treatment Sales Market Share by Country in 2021
Figure 48. Europe Graves Disease Treatment Revenue Market Share by Country in 2021
Figure 49. Germany Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Graves Disease Treatment Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Graves Disease Treatment Revenue Market Share by Country in 2021
Figure 56. Egypt Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Graves Disease Treatment in 2021
Figure 62. Manufacturing Process Analysis of Graves Disease Treatment
Figure 63. Industry Chain Structure of Graves Disease Treatment
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles